Drug Approval | March 09, 2024
Venus Remedies obtains marketing authorizations for essential oncology drugs in Ukraine
These approvals mark significant progress for Venus Remedies in expanding its market presence
These approvals mark significant progress for Venus Remedies in expanding its market presence
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Subscribe To Our Newsletter & Stay Updated
